Zero tolerance and the need for safer drug use limits

Guidelines exist for one of the world’s most dangerous and widely used drugs, alcohol. These were developed to help people and health care professionals have some idea what different level of drinking might be associated with low, moderate and high risk of harm. They are based on evidence, and although recent epidemiological data has probably underplayed the risks for cancer, properly used (e.g. within brief screening and intervention), they can help people reduce their drinking.

The problem is similar sensible guidelines don’t exist for illicit drugs. In most countries, the government line is basically, “Do not take illegal drugs because they are all bad.”

Just for the record (and the lawyers) the Global Drug Survey (GDS) states categorically that the only way to avoid all harm from drug use is to not use them. However, it’s not a very practical goal for people who like to indulge. The reality is that the risks of experiencing harms from using drugs can actually be massively reduced for most people with the right set of advice.

This is why GDS developed the world’s first Safer Using Limit guidelines. Using data collected from the 100,000 people who took part GDS2015, we are creating a number of guidelines, starting with cannabis, aimed at raising people’s awareness of the level of risk that different patterns of drug use places them at. We did this by asking respondents to rate how the risk of harm from different drugs (including alcohol) is heightened with increasing levels of use. “Risk” here refers to the probability, range and severity of harm. The higher the score, the more likely it is for a person to experience harms and problems, with higher scores indicating an increased severity of said harms. We also asked our respondents to think about the likelihood of a person experiencing harm over the next 1-2 years. By harm, we mean anything that causes a person problems, such as mental or physical health, relationships and behaviours, finances or ability to work, study, or just do the things in life they want to do.

Our first set of guidelines (on cannabis) was launch on June 18th 2015 at www.saferuselimits.co. Over 20,000 people have got their risk score so far.

Are drug users really the best experts?

A reasonable question to ask is, how valid are risk estimates based on the votes of a self-selecting group of drug users who surely have cognitive and emotional bias to minimize the risks associated with a consumptive behavior? I don’t know, but leave it to you to decide based the composite ratings from over 40,000 cannabis users that Professor Michael Linskey used to help develop the relative risk scores – shown below.

safer use screen shot

I came up with very similar ratings when I did the exercise blind before we launched GDS2015 last year. We hope to ask experts around the world to do the same thing in a project we are trying to set up to see the level of agreement between users and “experts.” The reality is, though, that the major driver for the approach we took was the fact that the people drug users trust most are other drugs users. Simply put, guidelines on safer-use limits voted by those who like to toke will be less quickly dismissed by other stoners.

I passionately believe that for most people who choose to use drugs and alcohol, they can be a source of pleasure that enhances the rich fabric of their lives. While I understand that drug use for some people is unwise (and best avoided) either because of their age, pre-existing health conditions or other vulnerabilities, the decision to use drugs is one that must always be treated with respect. I hope our work helps people, communities and governments have more honest conversations about drugs.

adam-winstock

Author: Dr. Adam R Winstock MBBS, BSc, MSc, MRCP, MRCPsych, FAChAM, MD
Founder and Director, Global Drug Survey; Consultant Psychiatrist and Addiction Medicine Specialist, SLAM NHS Trust; Senior Lecturer, Kings College London

Twitter:
@globaldrugsurvy
@drugsmeter

(Author’s note: Want to help contribute to this research? We will be launching GDS2016 in November, 2015 with focuses on psychedelics, safer MDMA dosing, drug vaping and drug tourism. We are hoping to increase our Canadian participation this year, so don’t hesitate to contact me if you would like to help us spread the word.)

 **Please note that the material presented here does not necessarily imply endorsement or agreement by individuals at the Centre for Addictions Research of BC

Let’s talk about pleasure: harm reduction by any other name

As a doctor who works with people whose lives have been severely affected by drugs, I realize that changing behavior, even when it is devastating to the individual, is very difficult. Part of the problem, as far as I see it, is that as a society we pay relatively little attention to people who use drugs until they either break the law or develop health problems.

The only form of prevention most governments consider is prevention of initiation of use. Such an approach, although valid and useful, means that the part of the community who are most at risk of developing problems (people who already use drugs) are devoid of any assistance in helping them monitor and self-regulate their consumption to reduce the risk of crossing that blurred boundary that divides problematic from non-problematic drug use. While a more honest discourse addressing harm-reduction strategies for users of all drugs is becoming more acceptable and available through the web-based user forums and drug information sites such as erowid, drugs-forum and blue-light, there is still a long way to go.

Pleasure drives drug use, not the avoidance of harm

I founded the Global Drug Survey (GDS) in 2011; in 2015, more than 100,000 people filled out our survey in 10 different languages. Our mission is to help people who choose to use drugs do so more safely and to provide independent, objective and credible information to individuals and their communities. Through our research and apps, GDS aims to help communities craft the most effective public health responses to the use of drugs, including alcohol and prescription medications.

The notion of engaging people in a conversation about harm reduction and discussing strategies that ‘allow’ them to continue to get pleasure from their drug use is still rather uncommon among drug-treatment services. I believe that if you can encourage behavior change that reduces risk but does not diminish pleasure, you are more likely to see your advice adopted.

The GDS has started that dialogue with the development of the GDS Highway Code, the world’s first harm-reduction guide voted for by people who use drugs (the people who are most trusted by other people who use drugs). It not only ranks different harm-reduction strategies by the proportion of users who normally adopt it and how important they perceive each one is in reducing risk of harm, but uniquely rates different strategies on the impact they have on drug-related pleasure. The headline conclusion is that safer drug use appears to be more enjoyable drug use. It has been downloaded over 80,000 times and translated into French and Portuguese.

The Highway Code shows how many respondents use this particular harm-reduction strategy as well as how much it reduces risk and enhances pleasure. Staying well hydrated was the #1 strategy used by MDMA users.
The Highway Code shows how many respondents use this particular harm-reduction strategy as well as how much it reduces risk and enhances pleasure. Staying well hydrated was the #1 strategy used by MDMA users.

Consequences not consumption

Another approach is to focus on possible social consequences of substance use. When it comes to alcohol, many interventions look at things like calories, units and health risks, which might not be as meaningful for younger people. Supported by findings from GDS2015 that social humiliation is in the top four motivators for changing drinking patterns, GDS has developed a microsite quiz for young drinkers.

After a brief survey, the "One too Many" app gives you an ARSE score.
After a brief survey, the “One too Many” app gives you an ARSE score.

The one too many app free at onetoomany.co is a novel way of getting young people to think about their drinking. While most digital interventions focus on how much you drink, one too many asks about behaviors that matter to young people. In just 20 questions covering things like losing your phone, passing out, or ending up in bed with someone you wish you hadn’t due to your drinking, one too many gives people a unique ARSE (Alcohol Related Social Embarrassment). And because we don’t always know what we are like when we are drinking, one too many allows you to send a link on Facebook and Twitter so your friends can anonymously give you an ARSE score (only you ever see the scores others give you). Over 200,000 people have got their ARSE score so far, and it’s about to be trailed and evaluated by a team at Oxford Brookes University.

GDS hopes that by compiling the world’s biggest database of drug use and by assessing both levels and patterns of use, our apps can provide critical, evidence-based feedback on health risks adjusted for a person’s unique medical, behavioral and familial history. We hope all of our work helps people use drugs more safely, so they remain a source of pleasure not pain to them, those they care for or their communities.

adam-winstock

Author: Dr. Adam R Winstock MBBS, BSc, MSc, MRCP, MRCPsych, FAChAM, MD
Founder and Director, Global Drug Survey; Consultant Psychiatrist and Addiction Medicine Specialist, SLAM NHS Trust; Senior Lecturer, Kings College London

Twitter:
@globaldrugsurvy
@drugsmeter

(Author’s note: Want to help contribute to this research? We will be launching GDS2016 in November, 2015 with focuses on psychedelics, safer MDMA dosing, drug vaping and drug tourism. We are hoping to increase our Canadian participation this year, so don’t hesitate to contact me if you would like to help us spread the word.)

 **Please note that the material presented here does not necessarily imply endorsement or agreement by individuals at the Centre for Addictions Research of BC